Sarepta Therapeutics, Inc (SRPT) insider trading
Every open-market stock purchase and sale by Sarepta Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $417K over the last 12 months (2 sales). No open-market buys.
- Last insider buy: Michael Andrew Chambers (Insider), $2.5M, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $417K (2 sales). Last close $15.55 on Jun 7, 2026.
Recent SRPT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 4, 2026 | Hans Lennart Rudolf Wigzell (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Richard Barry (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | M Kathleen Behrens (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Kathryn Jean Boor (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Deirdre P Connelly (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Michael Andrew Chambers (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Stephen Mayo (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Claude Nicaise (Insider) | Bought (not open market) | — |
| Mar 12, 2026 | Stephen Mayo (Insider) | Sold | $123K |
| Mar 11, 2026 | Ian Michael Estepan (COO) | Sold (not open market) | $18.7K |
| Mar 11, 2026 | Cristin Rothfuss (VP) | Sold (not open market) | $16.6K |
| Mar 11, 2026 | Louise Rodino-Klapac (President) | Sold (not open market) | $16.1K |
| Mar 11, 2026 | Ryan Ho-Yan Wong (CFO) | Sold (not open market) | $4.4K |
| Mar 9, 2026 | Ian Michael Estepan (COO) | Sold (not open market) | $17.6K |
| Mar 9, 2026 | Louise Rodino-Klapac (President) | Sold (not open market) | $15.2K |
| Mar 9, 2026 | Ian Michael Estepan (COO) | Sold (not open market) | $9.9K |
| Mar 9, 2026 | Louise Rodino-Klapac (President) | Sold (not open market) | $8.5K |
| Mar 9, 2026 | Cristin Rothfuss (VP) | Sold (not open market) | $8.2K |
| Mar 9, 2026 | Cristin Rothfuss (VP) | Sold (not open market) | $5.9K |
| Mar 9, 2026 | Ryan Ho-Yan Wong (CFO) | Sold (not open market) | $2.7K |
| Mar 9, 2026 | Ryan Ho-Yan Wong (CFO) | Sold (not open market) | $1.9K |
| Mar 2, 2026 | Louise Rodino-Klapac (President) | Sold (not open market) | $60.2K |
| Mar 2, 2026 | Ian Michael Estepan (COO) | Sold (not open market) | $53.5K |
| Mar 2, 2026 | Ian Michael Estepan (COO) | Sold (not open market) | $14.2K |
| Mar 2, 2026 | Louise Rodino-Klapac (President) | Sold (not open market) | $12.4K |
Who's trading SRPT
- Claude Nicaise, Insider: other filings, last Jun 4, 2026
- M Kathleen Behrens, Insider: other filings, last Jun 4, 2026
- Richard Barry, Insider: other filings, last Jun 4, 2026
- Kathryn Jean Boor, Insider: other filings, last Jun 4, 2026
- Michael Andrew Chambers, Insider: other filings, last Jun 4, 2026
- Deirdre P Connelly, Insider: other filings, last Jun 4, 2026
- Hans Lennart Rudolf Wigzell, Insider: other filings, last Jun 4, 2026
- Stephen Mayo, Insider: sold $123K (1 sale), last Jun 4, 2026
- Ryan Ho-Yan Wong, CFO: other filings, last Mar 11, 2026
- Cristin Rothfuss, VP: other filings, last Mar 11, 2026
- Louise Rodino-Klapac, C-suite exec: other filings, last Mar 11, 2026
- Ian Michael Estepan, CFO: sold $294K (1 sale), last Mar 11, 2026
- Douglas S Ingram, CEO: other filings, last Dec 7, 2025
Get free alerts when an insider at Sarepta Therapeutics, Inc files a new trade →